AG
GH icon

Algert Global’s Guardant Health GH Stock Holding History

Algert Global’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.6M Buy
64,000
+6,570
+11% +$715K 0.11% 281
2026
Q1 		$5.3M Sell
57,430
-81,302
-59% -$8.16M 0.08% 425
2025
Q4 		$14.2M Buy
138,732
+18,618
+16% +$1.67M 0.22% 109
2025
Q3 		$7.5M Buy
120,114
+75,474
+169% +$4.11M 0.13% 275
2025
Q2 		$2.32M Sell
44,640
-8,300
-16% -$371K 0.05% 582
2025
Q1 		$2.26M Buy
+52,940
New +$2.28M 0.06% 565
2024
Q3 		– Sell
-90,220
Closed -$2.61M – 1330
2024
Q2 		$2.61M Buy
90,220
+17,000
+23% +$396K 0.09% 381
2024
Q1 		$1.51M Sell
73,220
-628
-0.9% -$13.5K 0.06% 504
2023
Q4 		$2M Buy
73,848
+52,608
+248% +$1.38M 0.08% 420
2023
Q3 		$630K Sell
21,240
-27,340
-56% -$961K 0.03% 683
2023
Q2 		$1.74M Buy
+48,580
New +$1.4M 0.08% 437
2022
Q1 		– Sell
-4,458
Closed -$446K – 1225
2021
Q4 		$446K Hold
4,458
– – 0.06% 581
2021
Q3 		$557K Buy
+4,458
New +$530K 0.07% 499

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Algert Global's GH Position: Q2 2026 in Review

Algert Global increased its Guardant Health (GH) stake by 11% in Q2 2026, buying an estimated $715K and bringing the position to 64,000 shares worth $9.6M. The position accounts for 0.11% of the portfolio, ranked #281.

Algert Global first reported a position in GH in Q3 2021 and has held it in 13 quarters since. The position peaked at $14.2M in Q4 2025. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Algert Global held 64,000 shares of Guardant Health worth $9.6M as of Q2 2026.
  • Algert Global bought 6,570 Guardant Health shares in Q2 2026, an estimated $715K.
  • Guardant Health made up 0.11% of Algert Global's portfolio in Q2 2026, its #281 holding.
  • Algert Global first reported a position in Guardant Health in Q3 2021 and has held it in 13 quarters since.
  • Algert Global's Guardant Health position peaked at $14.2M in Q4 2025.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.